抑癌基因PRDM5在HPV16病毒致宫颈鳞癌发生过程中的作用研究

doi:10.11904/j.issn.1002-3070.2018.06.001

Abstract

Abstract: Objective The aim of this study was to explore whether the down-regulation of tumor suppressor gene PRDM5 is one of the mechanisms of HPV16 virus infection leading to cervical cancer. Methods The expressions of PRDM5 protein and HPV16 E6/HPV18 E6 protein in cervical cancer tissues and normal cervical tissues were detected by immunohistochemistry.After transfected with HPV16 E6 shRNA plasmid, the expression of PRDM5 gene was detected in SiHa cells by RT-PCR and Western blot. Results The positive expression rate of HPV 16/18 E6 in cervical cancer tissues was significantly higher than that in normal cervical tissues.The expression level of PRDM5 protein in cervical cancer tissues was lower than that in normal cervical tissues.After HPV16 E6 shRNA3 was transfected into SiHa cells to interfere with the expression of HPV16 E6 gene, the expression of PRDM5 at mRNA and protein levels was up-regulated in SiHa cells. Conclusion PRDM5 may mediate the development of cervical cancer caused by HPV16 virus infection.

Key words: Cervical cancer, PRDM5, HPV16, shRNA

CLC Number:

R735.7

CHENG Haiyan, MA Jing, FENG Ziwei, HUANG Kejin, WANG Yuxia, ZHANG Yunyan. Study on the mediating role of tumor suppressor gene PRDM5 in cervical squamous cell carcinoma induced by HPV16 virus[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 483-487.

References

1 Cinghu S, Anandharaj A, Lee HC, et al.FTS(fused toes homolog)a noval oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer[J].J Cell Physiol, 2011, 226(6):1564-1572.
2 Crosbie EJ, Einstein MH, Franceschi S, et al.Human papillomavirus and cervical cancer[J].Lancet, 2013, 382(9895):889-899.
3 Watanabe Y, Toyota M, Kondo Y, et al.PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer[J].Clin Cancer Res, 2007, 13(16):4786-4794.
4 Bond CE, Bettington ML, Pearson SA, et al.Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups[J].BMC Cancer, 2015, 15:20.
5 Tan SX, Hu RC, Liu JJ, et al.Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells[J].Int J Clin Exp Pathol, 2014, 7(5):2305-2311.
6 Cheng HY, Chen XW, Cheng L, et al.DNA methylation and carcinogenesis of PRDM5 in cervical cancer[J].J Cancer Res Clin Oncol, 2010, 136(12):1821-1825.
7 Watanabe Y, Kim HS, Castoro RJ, et al.Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes[J].Gastroenterology, 2009, 136(7):2149-2158.
8 张云艳, 刘亚琴, 王磊, 等.RIZ1蛋白表达与宫颈鳞状细胞癌临床病理参数及放疗敏感性的相关性研究[J].实用肿瘤学杂志, 2017, 31(5):405-410.
9 Tan SX, Hu RC, Tan YL, et al.Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma[J].Tumour Biol, 2014, 35(5):4509-4516.
10 Munger K, Howley PM.Human papillomavirus immortalization and transformation functions[J].Virus Res, 2002, 89(2):213-228.
11 Akagi K, Li J, Broutian TR, et al.Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability[J].Genome Res, 2014, 24(2):185-199.
12 Bodelon C, Vinokurova S, Sampson JN, et al.Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer[J].Carcinogenesis, 2016, 37(2):188-196.
13 Boon SS, Tomai＇c a V, Thomasa M, et al.Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions[J].J Virol, 2015, 89(3):1579-1586.
14 Jordanova ES, Kenter GG.High human papillomavirus oncogene mRNA expression and not vira DNA load is associated with poor prognosis in cervical cancer patients[J].Clin Cancer Res, 2007, 13(1):132-138.
15 Knopp S, Nesland JM, Tropé C, et al.p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma[J].Am J Clin Pathol, 2006, 126(2):266-276.

[1]	XU Hui, LI Xi, ZHOU Chunshui. Screening of lung cancer tumor-associated suppressor genes using shRNA library targeting human transcriptome [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 97-102.
[2]	LIANG Hong, LI Qi, WANG Yaoxian, JIN Hong, WANG Tong, WANG Yanan, DUAN Yani, SONG Min. Interrupted time series trial for prevention of cardiovascular toxicity induced by chemotherapy in cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 134-138.
[3]	QIN Wenyan, LU Yan. Advances in micrometastasis of sentinel lymph node in cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 571-574.
[4]	MENG Zhiying, YU Songtao, ZHANG Jingjing, JIN Huimin. Cervical carcinoma of mandible:A case report and literature review [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 122-124.
[5]	WANG Qinghui, SUN Yue, JIANG Wanwei. Clinical effect of flurbiprofen axetil in the postoperative analgesia of cervical cancer surgery [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 33-37.
[6]	LEI Lei, YE Qinghua, WANG Guozeng, HUANG Xianli, WU Qianyu. Expression of Aurora-A in cervical cancer and precancerous lesions,and its correlation with HPV infection [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 494-499.
[7]	ZHANG Yunyan, LIU Yaqin, WANG Lei, ZHANG Lin, CHENG Haiyan, YANG Shanshan. Relationship between expression of RIZ1 and clinicopathological factors or radiosensitivity in human cervical squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(5): 405-410.
[8]	YANG Yi,DING Yan,YU Aiqing,YAN Shirong. Effects of autophagy on the proliferation and migration of cervical cancer cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 481-486.
[9]	WU Yuliang,HE Songmei,ZHANG Chun,WU Weiyi,CUI Shunjing,ZHAO Yanhai. The effect of iterative times on the segment weight optimization in IMRT plan of postoperative cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 507-510.
[10]	SHENG Lei, WU Guizhen, HUERXIDAN Niyazi, ABULIZI Abudula. The expression of Th1/Th2 type cytokines and clinical significance in Uyghur cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 391-395.
[11]	WANG Zhenjun, ZHOU Honggui, ZHANG Miao, LIU Jun. Unexpected discovery of cervical cancer:one case report and literature review [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 441-443.
[12]	HU Yue,TANG Dong. Research of individual chemotherapy in patients with cervical cancer recurrence or continuous after radiation and chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(3): 240-244.
[13]	WANG Mingtao, WANG Jing. The analysis of factors affecting the prognosis of 519 patients with cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 512-517.
[14]	CHE Aiwen,CHEN Shuping,TAN Xudong,LI Jialiang,MA Hongmei. The expression and clinic significance of CIP2A and HPV16-E7 protein in cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(1): 29-33.
[15]	ZHU Hong,ZHU Li,HAN Shiyu,FANG Fang,YU Yang. The predictive value of DWI for progression free survival in patients with cervix cancer after neoadjuvant chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2014, 28(6): 519-523.

Study on the mediating role of tumor suppressor gene PRDM5 in cervical squamous cell carcinoma induced by HPV16 virus

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments